Ligand profile
ZINC26461460
Virtual-screening candidate from ZINC.
Bound to: KP13_01038 — Chorismate synthase
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC26461460- UniProt (similar protein)
P0A2Y6- Tanimoto
- 0.614
- Target protein
- KP13_01038
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 46.5
- −1 ≤ LogP ≤ 5 3.46
- MW ≤ 500 Da 270.3
- LogP ≤ 5 3.46
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 3
- Rotatable bonds ≤ 10 1
- TPSA ≤ 140 Ų 46.5
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
Cc1c(O)ccc2c1O/C(=C\c1ccccc1F)C2=OCc1c(O)ccc2c1O/C(=C\c1ccccc1F)C2=O
InChI=1S/C16H11FO3/c1-9-13(18)7-6-11-15(19)14(20-16(9)11)8-10-4-2-3-5-12(10)17/h2-8,18H,1H3/b14-8-InChI=1S/C16H11FO3/c1-9-13(18)7-6-11-15(19)14(20-16(9)11)8-10-4-2-3-5-12(10)17/h2-8,18H,1H3/b14-8-
QLSCUJFIOCWBDA-ZSOIEALJSA-NQLSCUJFIOCWBDA-ZSOIEALJSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- CHEMBL134100
- Homolog
- P0A2Y6
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC26461460 →
- ZINC ZINC20 ZINC26461460 →
- UniProt UniProt P0A2Y6 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC26461460”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_01038.
ChEMBL 11
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).